NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.

Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.

U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

PUBLICATIONS

228Th breakthrough in 224Ra samples: what can we know and when can we know it?

Published

Author(s)

Denis E. Bergeron, Leticia S. Pibida, Ryan P. Fitzgerald
Citation
ACS Spring 2020 National Meeting & Expo
Pub Weblink
https://www.morressier.com/acs-2020-expo/5e733c5acde2b641284a7e27?filter_sympos…
Pub Type
Websites

Download Paper

https://doi.org/10.1021/scimeetings.0c01048
Local Download

Keywords

targeted alpha therapy, impurities, breakthrough, Monte Carlo, radioactivity, dose
Radiation, Precision medicine, Biopharmaceuticals and Nuclear physics

Citation

Bergeron, D. , Pibida, L. and Fitzgerald, R. (2020), 228Th breakthrough in 224Ra samples: what can we know and when can we know it?, ACS Spring 2020 National Meeting & Expo, [online], https://doi.org/10.1021/scimeetings.0c01048, https://www.morressier.com/acs-2020-expo/5e733c5acde2b641284a7e27?filter_symposia=Radiotherapeutics%3A%20From%20Isotope%20Production%20to%20Targeted%20Delivery (Accessed October 9, 2025)

Issues

If you have any questions about this publication or are having problems accessing it, please contact [email protected].

Created April 6, 2020, Updated June 6, 2020
Was this page helpful?